Other engineering approaches to increase anti-tumor efficacy include insertion of a transgene encoding the proapoptotic protein BNiP3 [49] and the angiogenesis inhibitors endostatin and angiostatin to remodel the tumor microenvironment [98]. This evidence concerns the gene BNIP3 and neoplasm.